(Press-News.org) A clinical trial on a two-drug therapy for methamphetamine use disorder reduced use of the highly addictive drug for up to 12 weeks after initiation of treatment, UCLA-led research suggests.
Participants in the ADAPT-2 clinical trial who received a combination of injectable naltrexone plus extended-release oral bupropion (NTX+BUPN) had a 27% increase in methamphetamine-negative urine tests, indicating reduced usage. By contrast, the placebo group had an 11% increase in negative tests.
The study will be published in the peer-reviewed journal Addiction.
“These findings have important implications for pharmacological treatment for methamphetamine use disorder. There is no FDA-approved medication for it, yet methamphetamine-involved overdoses have greatly increased over the past decade,” said Dr. Michael Li, assistant professor-in-residence of family medicine at the David Geffen School of Medicine at UCLA and the study’s lead author.
Methamphetamine use has continued growing over the years around the world, increasing from 33 million people in 2010 to 34 million in 2020. Overdose deaths from the drug have jumped fivefold in the US from 2012 to 2018, and are followed by Canada and Australia in increases.
To curb the ongoing crisis, the National Institute on Drug Abuse (NIDA) Clinical Trials Network has supported various trials, including the ADAPT-2 trial, to test the effects of different pharmacological treatments for methamphetamine use disorder. ADAPT-2 was carried out from May 23, 2017 to July 25, 2019 across the eight trial sites that included UCLA. It included 403 participants, with 109 assigned to the drug combo group and the rest to the placebo group in the first stage.
The latest findings are the second stage of the multi-site trial. The earlier stage had demonstrated that the two-drug combination worked at six weeks, but the unanswered question was whether the intervention remained efficacious over a longer period.
In the second stage, the researchers conducted urine tests on the participants at weeks seven and 12, and again post-treatment at weeks 13 and 16 comparing the group on NTX+BUPN with the placebo group.
There is a need for further research to determine whether the drug treatment effect lasts longer than 12 weeks and yields further methamphetamine use reductions, the researchers write.
“Prior stimulant use disorder treatment trials suggest that change in use is gradual (consistent with our findings), unlikely to result in sustained abstinence in a typical 12-week trial, and dependent on treatment duration,” they write. “This warrants future clinical trials to quantify changes in MA use beyond 12 weeks and to identify the optimal duration of treatment with this medication.”
Study co-authors are Brendon Chau, Thomas Belin, and Steven Shoptaw of UCLA, and Thomas Carmody, Manish Jha, Elise Marino, and Dr. Madhukar Trivedi of the University of Texas.
The study was funded by awards from the National Institute on Drug Abuse of the U.S. National Institutes of Health (UG1DA020024, K01DA051329, UG1DA013035, UG1DA040316, UG1DA013727, and UG1DA015815), the U.S. Department of Health and Human Services under contract numbers HHSN271201500065C (Clinical Coordinating Center, the Emmes Company) and HHSN271201400028C (Data and Statistics Center, the Emmes Company), the U.S. National Institute of Mental Health (K23MH126202) and the O’Donnell Clinical Neuroscience Scholar Award from the University of Texas, Southwestern Medical Center.
END
Clinical trial shows promising results in a two-drug combination that curbs methamphetamine use
2024-06-10
ELSE PRESS RELEASES FROM THIS DATE:
Gut microbes from aged mice induce inflammation in young mice, study finds
2024-06-10
CHAMPAIGN, Ill. — When scientists transplanted the gut microbes of aged mice into young “germ-free” mice — raised to have no gut microbes of their own — the recipient mice experienced an increase in inflammation that parallels inflammatory processes associated with aging in humans. Young germ-free mice transplanted with microbes from other young mice had no such increase.
The findings suggest that changes to the gut microbiome play a role in the systemwide inflammation that often occurs ...
Valentin Fuster, MD, Ph.D., received 2024 Distinguished Award from European Society for Clinical Investigation (ESCI)
2024-06-10
The European Society for Clinical Investigation (ESCI) is awarding Valentin Fuster, MD, PhD, President of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital, its ESCI Distinguished Medal for 2024. He received this honor during the ESCI Annual Scientific Meeting in Barcelona, Spain, during a special ceremony on Friday, June 7.
The ESCI Medal is awarded yearly for outstanding achievements in clinical investigation and for the teaching of young scientists and medical specialists.
This prestigious recognition highlights Dr. Fuster’s significant contributions to the worldwide field of cardiology. Dr. Fuster’s work has been ...
Planetary Health Diet associated with lower risk of premature death, lower environmental impact
2024-06-10
Embargoed for release: Monday, June 10, 7:00 AM ET
Key takeaways:
People whose diets most closely adhered to the Planetary Health Diet (PHD) had 30% lower risk of premature death compared to those with the lowest adherence.
Every major cause of death, including cancer, heart disease, and lung disease, was lower with greater adherence to this dietary pattern.
Diets adhering to the PHD pattern had substantially lower environmental impact, including 29% lower greenhouse gas emissions and 51% less land use.
Boston, MA—People who eat a healthy, sustainable diet may ...
Improved prime editing system makes gene-sized edits in human cells at therapeutic levels
2024-06-10
Scientists at the Broad Institute of MIT and Harvard have improved a gene-editing technology that is now capable of inserting or substituting entire genes in the genome in human cells efficiently enough to be potentially useful for therapeutic applications.
The advance, from the lab of Broad core institute member David Liu, could one day help researchers develop a single gene therapy for diseases such as cystic fibrosis that are caused by one of hundreds or thousands of different mutations in a gene. Using this new approach, they would insert a healthy copy of the gene at its native location in the genome, rather than having to create a different ...
Lung organoids unveil secret: How pathogens infect human lung tissue
2024-06-10
How do pathogens invade the lungs? Using human lung microtissues, a team at the Biozentrum of the University of Basel has uncovered the strategy used by a dangerous pathogen. The bacterium targets specific lung cells and has developed a sophisticated strategy to break through the lungs’ line of defense.
Earlier this year, the WHO published a list of twelve of the world’s most dangerous bacterial pathogens that are resistant to multiple antibiotics and pose a grave threat to human health. This list includes Pseudomonas aeruginosa, a much-feared nosocomial pathogen ...
The solar system may have passed through dense interstellar clouds 2 million years ago, altering Earth’s climate
2024-06-10
Around two million years ago, Earth was a very different place, with our early human ancestors living alongside saber-toothed tigers, mastodons, and enormous rodents. And, depending on where they were, they may have been cold: Earth had fallen into a deep freeze, with multiple ice ages coming and going until about 12,000 years ago. Scientists theorize that ice ages occur for a number of reasons, including the planet’s tilt and rotation, shifting plate tectonics, volcanic eruptions, and carbon dioxide levels in the atmosphere. ...
Miniaturizing a laser on a photonic chip
2024-06-10
Lasers have revolutionized the world since the 60’s and are now indispensable in modern applications, from cutting-edge surgery and precise manufacturing to data transmission across optical fibers.
But as the need for laser-based applications grows, so do challenges. For example, there is a growing market for fiber lasers, which are currently used in industrial cutting, welding, and marking applications.
Fiber lasers use an optical fiber doped with rare-earth elements (erbium, ytterbium, neodymium etc) as their optical gain source (the part that produces the laser’s light). They emit high-quality beams, they have high power output, and they are efficient, ...
Study: Physical activity in the evening lowers blood sugar levels
2024-06-10
ROCKVILLE, Md.— New research reveals that moderate to vigorous physical activity in the evening for sedentary adults with overweight and obesity is most beneficial in lowering daily blood sugar levels, according to a study published in Obesity, The Obesity Society’s (TOS) flagship journal.
Experts explain that it has been well established that moderate to vigorous physical activity enhances glucose homeostasis in adults with overweight and obesity who are at higher risk of developing insulin resistance. ...
Experts develop nutritional recommendations for patients treated with anti-obesity medications
2024-06-10
ROCKVILLE, Md.— Individuals treated with anti-obesity medications generally experience reduced appetite, which typically leads to reduced food intake. As a result, dietary quality becomes more important because nutritional needs must be met within the context of eating less. To improve this process, medical experts have developed a list of evidence-based nutritional recommendations to assist clinicians treating patients with anti-obesity medications, according to a review published in the journal Obesity, The Obesity Society’s (TOS) flagship journal.
“Our evidence-based review aims to equip clinicians with knowledge ...
Peers crucial in shaping boys’ confidence in math skills
2024-06-10
Boys are good at math, girls not so much? A study from the University of Zurich has analyzed the social mechanisms that contribute to the gender gap in math confidence. While peer comparisons seem to play a crucial role for boys, girls’ subjective evaluations are more likely to be based on objective performance.
Research has shown that in Western societies, the average secondary school girl has less confidence in her mathematical abilities than the average boy of the same age. At the same time, no significant difference ...